Novo cancels haemophilia drug Phase III trial
Haemophilia is a mostly inherited genetic disorder that impairs the body’s ability to make blood clots.
Read More
Author: Anna Smith
New research discovers cells linked to Alzheimer’s and autism
The new insight into the architecture of the brain is the most in-depth study of its kind.
Read More
PrEP to be available in England from April
Local authorities will receive £16 million in 2020 to 2021 to deliver the preventative HIV treatment.
Read More
Jardiance bags FDA Fast Track designation
The decision follows a Jardiance Fast Track designation which was granted by the FDA in July 2019 for the risk of cardiovascular death.
Read More
Risk of death by stroke down 24%
Stroke is the fourth single leading cause of death in England and Wales.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
